BioScrip (BIOS) Misses Q3 EPS by 28c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/13/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
BioScrip Reports Third Quarter 2015 Financial Results
November 4, 2015 7:00 AM ESTConsolidated Adjusted EBITDA of $6.2 Million
Results Demonstrate Progress Against Financial Improvement Plan
Reaffirms 2016 Adjusted EBITDA Guidance of Between $50 Million - $60 Million
ELMSFORD, N.Y.--(BUSINESS WIRE)-- BioScrip, Inc. (NASDAQ: BIOS) (the Company) today announced 2015 third quarter financial results.
Third Quarter Highlights
Consolidated Adjusted EBITDA was $6.2 million, primarily due to the early positive contributions of BioScrips previously announced plan to reduce costs and focus on its core infusion business; Revenue... More